(Q37990676)

26 August 2017

title

The science and practice of lithium therapy (English)

1 reference

26 August 2017

0 references

4

1 reference

26 August 2017

Pritha Das

3

0 references

Gin Malhi

series ordinal

1

object named as

Gin S Malhi

1 reference

26 August 2017

2

Michelle Tanious

1 reference

26 August 2017

publication date

1 March 2012

1 reference

Australian and New Zealand Journal of Psychiatry

26 August 2017

published in

1 reference

26 August 2017

volume

46

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

192-211

1 reference

Knockout mice in understanding the mechanism of action of lithium

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Treatment of bipolar disorder: new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Extending indications for long-term pharmacotherapy: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Does lithium treatment still work? Evidence of stable responses over three decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

The thyroid-brain interaction in thyroid disorders and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Kidney function in lithium-treated patients. A literature survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Drug-induced diabetes insipidus: incidence, prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Enhancing medication adherence in patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Development of guidelines for caregivers of people with bipolar disorder: a Delphi expert consensus study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Neuroprogression: pathways to progressive brain changes in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

A collaborative approach to the treatment alliance in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

The ability of lithium and other mood stabilizers to decrease suicide risk and prevent relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Relapse into mania or depression following lithium discontinuation: a 7-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Explicit and implicit facial affect recognition in manic and depressed States of bipolar disorder: a functional magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Implication of serum concentration monitoring in patients with lithium intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

A reevaluation of risk of in utero exposure to lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Rapid cycling bipolar disorder: clinical characteristics and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Cellular consequences of inositol depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Assessment and treatment of bipolar disorder in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

N-Acetylcysteine ameliorates lithium-induced renal failure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Characteristics of voluntary participants versus nonparticipants in a psychoeducation program for euthymic patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Effect of chronic lithium and withdrawal from chronic lithium on presynaptic dopamine function in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Effect of lithium and lithium withdrawal on potassium-evoked dopamine release and tyrosine hydroxylase expression in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Clinical relevance of drug interactions with lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

An update of evidence-based treatment of bipolar depression: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Treatment of bipolar depression: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium: clinical considerations in internal medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium specificity in bipolar illness: a classic agent for the classic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium and the kidney: an updated review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Suicide risk in bipolar disorder during treatment with lithium and divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

What is a mood stabilizer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium: updated human knowledge using an evidence-based approach: Part I: Clinical efficacy in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Steady-state pharmacokinetics of lithium carbonate in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium-associated clinical hypothyroidism. Prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Acute and chronic effects of lithium chloride on physiological and psychological measures in normals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Does lithium protect against dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Increased motor activity and recurrent manic episodes: predictors of rapid relapse in remitted bipolar disorder patients after lithium discontinuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Is polarity of recurrence related to serum lithium level in patients with bipolar disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Changes in learning, memory, and mood during lithium treatment. Approach to a research strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

The effects of lithium therapy on thyroid and thyrotropin-releasing hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Longitudinal studies on the rate of decline in renal function with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium: a review of its metabolic adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium treatments: single and multiple daily dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Effects of lithium treatment on hypothalamic-pituitary-thyroid axis: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Hazards and adverse effects of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

The king is dead, long live the king! The restoration of BALANCE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Is lithium in a class of its own? A brief profile of its clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Medicating mood with maintenance in mind: bipolar depression pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

The management of individuals with bipolar disorder: a review of the evidence and its integration into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Clinical practice recommendations for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Clinical practice recommendations for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Hypomania: hype or mania?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Atypical mood stabilizers: a new role for neuroleptics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Bipolar depression: management options

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

The lithiumeter: a measured approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Rapid recurrence of mania following abrupt discontinuation of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Signaling: cellular insights into the pathophysiology of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium: bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Caffeine withdrawal increases lithium blood levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium and eGFR: a new routinely available tool for the prevention of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Pharmacologic treatment of rapid cycling and mixed states in bipolar disorder: an argument for the use of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

New treatment guidelines for acute bipolar depression: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium toxicity: an iatrogenic problem in susceptible individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Validating GSK3 as an in vivo target of lithium action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Clinical manifestations and management of acute lithium intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Cardiac sinus node dysfunction during lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Sinus node dysfunction during long-term lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Excellent lithium responders have normal cognitive functions and plasma BDNF levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Prospective studies on a lithium cohort. 2. Renal function. Water and electrolyte metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Olanzapine vs. lithium in management of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium for older adults with bipolar disorder: Should it still be considered a first-line agent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Brain lithium concentrations in bipolar disorder patients: preliminary (7)Li magnetic resonance studies at 3 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Differential pharmacokinetics of lithium in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Effects of lithium carbonate on memory and other cognitive functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Activation of Akt by lithium: pro-survival pathways in aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Hippocampal morphology in lithium and non-lithium-treated bipolar I disorder patients, non-bipolar co-twins, and control twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Efficacy and acceptability of mood stabilisers in the treatment of acute bipolar depression: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Prospective studies on a lithium cohort. 3. Tremor, weight gain, diarrhea, psychological complaints

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Treatment options for bipolar depression: a systematic review of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

A comparative double-blind study of the side effects of Litarex and Lithionit Durettes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Reformulation of current recommendations for target serum lithium concentration according to clinical indication, age and physical comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Prophylactic therapy with lithium in elderly patients with unipolar major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium use and the risk of fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Effects of lithium on cognitive performance: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Psychotropic drugs in mothers' milk: a comprehensive review of assay methods, pharmacokinetics and of safety of breast-feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Lithium in mood disorders: increasing evidence base, declining use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

A Randomized Trial on the Efficacy of Group Psychoeducation in the Prophylaxis of Recurrences in Bipolar Patients Whose Disease Is in Remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Should antipsychotics take pole position in mania treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

Rapid Cycling Bipolar Disorder: Phenomenology and Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412437346

21 January 2018

Identifiers

DOI

10.1177/0004867412437346

1 reference

26 August 2017

1 reference